StockMacro
Menu

IGC Pharma

$0.17 -41% in 6 monthsMarket cap $19.6M

IGC on XASE, Health Care, IGC Pharma, Inc., job postings

Measures activity, not value. Not investment advice.

Cash of only $413K against an $8.1M 12-month net loss, while the stock fell 46% in a year.

  • BadInstitutional holders fell to 29 from 36 the quarter before, down 19%
  • GoodRevenue grew 14% over 12 months to $1.3M

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Industry
Pharmaceutical preparations (Health Care)
Employees
70
Website
igcinc.us
Listed
NYSE American, US
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $328K, net loss $2.0M.
Quarter to 31 Dec 2021: revenue $142K, net income -$2.4MQuarter to 31 Dec 2021: revenue $142K, net income -$2.4MQuarter to 31 Mar 2022: revenue $122K, net income -$6.5MQuarter to 31 Mar 2022: revenue $122K, net income -$6.5MQuarter to 30 Jun 2022: revenue $212K, net income -$2.8MQuarter to 30 Jun 2022: revenue $212K, net income -$2.8MQuarter to 30 Sep 2022: revenue $202K, net income -$2.4MQuarter to 30 Sep 2022: revenue $202K, net income -$2.4MQuarter to 31 Dec 2022: revenue $332K, net income -$2.2MQuarter to 31 Dec 2022: revenue $332K, net income -$2.2MQuarter to 31 Mar 2023: revenue $166K, net income -$4.0MQuarter to 31 Mar 2023: revenue $166K, net income -$4.0MQuarter to 30 Jun 2023: revenue $555K, net income -$2.1MQuarter to 30 Jun 2023: revenue $555K, net income -$2.1MQuarter to 30 Sep 2023: revenue $291K, net income -$2.5MQuarter to 30 Sep 2023: revenue $291K, net income -$2.5MQuarter to 31 Dec 2023: revenue $204K, net income -$5.6MQuarter to 31 Dec 2023: revenue $204K, net income -$5.6MQuarter to 31 Mar 2024: revenue $295K, net income -$2.9MQuarter to 31 Mar 2024: revenue $295K, net income -$2.9MQuarter to 30 Jun 2024: revenue $272K, net income -$2.4MQuarter to 30 Jun 2024: revenue $272K, net income -$2.4MQuarter to 30 Sep 2024: revenue $412K, net income -$1.7MQuarter to 30 Sep 2024: revenue $412K, net income -$1.7MQuarter to 31 Dec 2024: revenue $257K, net income -$1.8MQuarter to 31 Dec 2024: revenue $257K, net income -$1.8MQuarter to 31 Mar 2025: revenue $330K, net income -$1.2MQuarter to 31 Mar 2025: revenue $330K, net income -$1.2MQuarter to 30 Jun 2025: revenue $328K, net income -$1.6MQuarter to 30 Jun 2025: revenue $328K, net income -$1.6MQuarter to 30 Sep 2025: revenue $191K, net income -$1.8MQuarter to 30 Sep 2025: revenue $191K, net income -$1.8MQuarter to 31 Dec 2025: revenue $350K, net income -$726KQuarter to 31 Dec 2025: revenue $350K, net income -$726KQuarter to 31 Mar 2026: revenue $317K, net income -$2.4MQuarter to 31 Mar 2026: revenue $317K, net income -$2.4MQuarter to 30 Jun 2026: revenue $265K, net income -$2.9MQuarter to 30 Jun 2026: revenue $265K, net income -$2.9MQuarter to 30 Sep 2026: revenue $328K, net income -$2.0MQuarter to 30 Sep 2026: revenue $328K, net income -$2.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $6.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$328K-$2.0M
30 Jun 2026$265K-$2.9M
31 Mar 2026$317K-$2.4M
31 Dec 2025$350K-$726K
30 Sep 2025$191K-$1.8M
30 Jun 2025$328K-$1.6M
31 Mar 2025$330K-$1.2M
31 Dec 2024$257K-$1.8M
30 Sep 2024$412K-$1.7M
30 Jun 2024$272K-$2.4M
31 Mar 2024$295K-$2.9M
31 Dec 2023$204K-$5.6M
30 Sep 2023$291K-$2.5M
30 Jun 2023$555K-$2.1M
31 Mar 2023$166K-$4.0M
31 Dec 2022$332K-$2.2M
30 Sep 2022$202K-$2.4M
30 Jun 2022$212K-$2.8M
31 Mar 2022$122K-$6.5M
31 Dec 2021$142K-$2.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.3M $1.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +14% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$8.1M -$6.4M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.08 -$0.08
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 16.5% 46.2% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -803% -732% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -644% -583% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -111% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$5.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $413K $1.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $136K
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – -$994K
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.06
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 15.6 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.0 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
IGC PharmaIGC (this company) $19.6Mloss15.6+14%-644%
TherapeuticsMDTXMD $19.8M1625.3+34%3.3%
Edesa BiotechEDSA $19.3Mloss–––
Adicet BioACET $20.0Mloss–––
TransCode TherapeuticsRNAZ $20.1Mloss–––
Aardvark TherapeuticsAARD $20.2Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-19%

29 13F filers vs 36

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

5.4%

6.3M shares held by 13F filers (30 Sep 2026) of 116.7M outstanding (3 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0.3%

396K shares sold short (30 Oct 2026) of 116.7M outstanding (3 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.0

396K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-38%

636K shares sold short in the report before, 396K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

27%

27% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 41%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.0×

6 articles in the last 7 days; its usual week has 1.

Price $0.17 on 20 Nov 2026, -46% over 12 months (12-month range $0.17 to $0.35)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $0).
Revenue per quarter. Revenue $328K in the latest quarter, +72% on a year earlier.
Capital spending per quarter. Capital spending $5K in the latest quarter, -38% on a year earlier.
Institutional holders (13F filers). 29 13F filers reported holding it in the latest 13F quarter, -15% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
14 Nov 20258-K and other filingsCompleted an acquisition or asset sale
29 Jul 2025Sharp changeShort interest spike: short interest spike, 3.5M vs usual 964K (2025-07-15); 3.1x the same period a year earlier
15 Oct 2024Sharp changeShort interest spike: short interest spike, 1.7M vs usual 950K (2024-09-30); 2.1x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 1.2M vs usual 898K (2024-06-28); 1.4x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 1.3M vs usual 883K (2024-06-14); 1.5x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 1.4M vs usual 883K (2024-05-31); 1.5x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 1.3M vs usual 883K (2024-05-15); 1.5x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 1.2M vs usual 883K (2024-04-30); 1.1x the same period a year earlier
13 Mar 20248-K and other filingsDirector or officer change
13 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jun 20238-K and other filingsReport will be filed late
5 May 20238-K and other filingsDirector or officer change
5 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Dec 20228-K and other filingsDirector or officer change
29 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Sep 20228-K and other filingsDirector or officer change
9 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Mar 20228-K and other filingsDirector or officer change
18 Jan 20228-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Sep 2024: $200K published
Revenue per quarter
Quarter ended 31 Dec 2021: $142K, +31% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $122K, +51% on a year earlier; public on 24 Jun 2022
Quarter ended 30 Jun 2022: $212K, +175% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $202K, +261% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $332K, +134% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $166K, +36% on a year earlier; public on 8 Jul 2023
Quarter ended 30 Jun 2023: $555K, +162% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $291K, +44% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $204K, -39% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $295K, +78% on a year earlier; public on 25 Jun 2024
Quarter ended 30 Jun 2024: $272K, -51% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $412K, +42% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $257K, +26% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $330K, +12% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2025: $328K, +21% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $191K, -54% on a year earlier; public on 15 Nov 2025
Quarter ended 31 Dec 2025: $350K, +36% on a year earlier; public on 19 Mar 2026
Quarter ended 31 Mar 2026: $317K, -3.9% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $265K, -19% on a year earlier; public on 15 Aug 2026
Quarter ended 30 Sep 2026: $328K, +72% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $27K, -82% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $55K, -38% on a year earlier; public on 24 Jun 2022
Quarter ended 30 Jun 2022: $127K, +37% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Jun 2023: $20K, -84% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $35K; public on 13 Nov 2024
Quarter ended 31 Dec 2023: $68K; public on 15 Feb 2025
Quarter ended 31 Mar 2024: $15K; public on 25 Jun 2024
Quarter ended 30 Jun 2024: $38K, +90% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $29K, -17% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $27K, -60% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $18K, +20% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2025: $8K, -79% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $29K, 0% on a year earlier; public on 7 Nov 2026
Quarter ended 31 Dec 2025: $12K, -56% on a year earlier; public on 19 Mar 2026
Quarter ended 31 Mar 2026: $1K, -94% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $5K, -38% on a year earlier; public on 15 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 27; public on 14 Feb 2022
31 Mar 2022 report: 26; public on 16 May 2022
30 Jun 2022 report: 27; public on 15 Aug 2022
30 Sep 2022 report: 24; public on 14 Nov 2022
31 Dec 2022 report: 22; public on 14 Feb 2023
31 Mar 2023 report: 21; public on 15 May 2023
30 Jun 2023 report: 21; public on 14 Aug 2023
30 Sep 2023 report: 24; public on 14 Nov 2023
31 Dec 2023 report: 23; public on 14 Feb 2024
31 Mar 2024 report: 23; public on 15 May 2024
30 Jun 2024 report: 21; public on 14 Aug 2024
30 Sep 2024 report: 22; public on 14 Nov 2024
31 Dec 2024 report: 30; public on 14 Feb 2025
31 Mar 2025 report: 25; public on 15 May 2025
30 Jun 2025 report: 26; public on 14 Aug 2025
30 Sep 2025 report: 34; public on 14 Nov 2025
31 Dec 2025 report: 29; public on 17 Feb 2026
31 Mar 2026 report: 35; public on 15 May 2026
30 Jun 2026 report: 36; public on 14 Aug 2026
30 Sep 2026 report: 29; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $200K (27 Sep 2024), higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $0).
  • Revenue per quarter: Revenue $328K in the latest quarter, +72% on a year earlier.
  • Capital spending per quarter: Capital spending $5K in the latest quarter, -38% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 15 insider trades

No trades in the last 90 days; the latest was filed 27 Sep 2024. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
27 Sep 2024James P MoranDirectorBuy588,235$0.34$200KForm 4
10 Mar 2021Richard K PrinsDirectorSell50,000$1.75$88KForm 4
8 Mar 2021Richard K PrinsDirectorSell50,000$1.80$90KForm 4
8 Mar 2021Ram MukundaExec. Chairman & CEOSell50,000$2.14$107KForm 4
4 Dec 2020Richard K PrinsDirectorSell50,000$2.04$102KForm 4
2 Dec 2020Ram MukundaExec. Chairman & CEOSell80,000$2.34$187KForm 4
12 Jun 2019Richard K PrinsDirectorSell50,000$1.08$54KForm 4
31 Aug 2018Claudia GrimaldiVice President and PFOSell116,020$2.00$232KForm 4

29 institutions reported shares at the end of Q3 2026, 5% of the shares outstanding; 2 opened a position, 10 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Geode Capital Management, LLC1.0M0.89%$280K+162K+18%
AdvisorShares Investments LLC939K0.81%$253K+261K+38%
Vanguard Capital Management LLC871K0.75%$234K+56K+6.8%
Citadel Advisors LLC736K0.63%$198K+298K+68%
BlackRock, Inc.704K0.60%$189KNo change
Renaissance Technologies LLC653K0.56%$176K+367K+128%
Vanguard Fiduciary Trust Co419K0.36%$113KNo change
State Street Corp275K0.24%$74K+74K+37%
Northern Trust Corp170K0.15%$46KNo change
UBS Group AG99K0.08%$27K+99K98,716 times as many

Company events

All 66 company events

In 12 months: 5 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
6 Jul 2026Signed a major agreementSame filing: sold shares privately8-K
8 Jun 2026Signed a major agreementSame filing: took on new debt8-K
20 Apr 2026Signed a major agreementSame filing: took on new debt, sold shares privately8-K
11 Mar 2026Signed a major agreementSame filing: took on new debt, sold shares privately8-K
5 Jan 2026Signed a major agreement8-K
14 Nov 2025Completed an acquisition or asset sale8-K
1 Oct 2025Signed a major agreement8-K
27 Sep 2024Signed a major agreementSame filing: sold shares privately8-K

The 5 newest of 57 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 14 Nov 2025Filings record

    Completed an acquisition or asset sale

  2. 25 Jul 2025Short interest and volume change

    had 3.5M shares sold short in the 15 Jul 2025 report, 3.1× the same report last year.

    Same report last year: 1.1M; its normal report is 964K.

    See the evidence
    This period
    3.5M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    183K
    How far from its usual level
    +9.2
    Same report last year
    1.1M
    History used
    2,755 days
    2024-07-15: 1.1M2024-07-31: 1.2M2024-08-15: 1.2M2024-08-30: 1.3M2024-09-13: 1.0M2024-09-30: 1.7M2024-10-15: 1.3M2024-10-31: 1.2M2024-11-15: 1.1M2024-11-29: 1.0M2024-12-13: 812K2024-12-31: 768K2025-01-15: 1.0M2025-01-31: 953K2025-02-14: 813K2025-02-28: 944K2025-03-14: 974K2025-03-31: 793K2025-04-15: 802K2025-04-30: 685K2025-05-15: 653K2025-05-30: 590K2025-06-13: 526K2025-06-30: 510K2025-07-15: 3.5M
    the 15 Jul 2025 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 10 Oct 2024Short interest and volume change

    had 1.7M shares sold short in the 30 Sep 2024 report, 2.1× the same report last year.

    Same report last year: 797K; its normal report is 950K.

    See the evidence
    This period
    1.7M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    950K
    Typical spread (median absolute deviation)
    110K
    How far from its usual level
    +4.3
    Same report last year
    797K
    History used
    2,467 days
    2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M2024-05-15: 1.3M2024-05-31: 1.4M2024-06-14: 1.3M2024-06-28: 1.2M2024-07-15: 1.1M2024-07-31: 1.2M2024-08-15: 1.2M2024-08-30: 1.3M2024-09-13: 1.0M2024-09-30: 1.7M
    the 30 Sep 2024 report24 earlier reportsnormal: 950K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 28 Sep 2024Insiders record

    Moran James P (director) bought 588,235 shares of IGC ($200,000) (dated 27 Sep 2024)

  5. 11 Jul 2024Short interest and volume change

    had 1.2M shares sold short in the 28 Jun 2024 report, 1.4× the same report last year.

    Same report last year: 862K; its normal report is 898K.

    See the evidence
    This period
    1.2M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    898K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +3.8
    Same report last year
    862K
    History used
    2,373 days
    2023-06-30: 862K2023-07-14: 844K2023-07-31: 800K2023-08-15: 795K2023-08-31: 851K2023-09-15: 886K2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M2024-05-15: 1.3M2024-05-31: 1.4M2024-06-14: 1.3M2024-06-28: 1.2M
    the 28 Jun 2024 report24 earlier reportsnormal: 898K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 27 Jun 2024Short interest and volume change

    had 1.3M shares sold short in the 14 Jun 2024 report, 1.5× the same report last year.

    Same report last year: 865K; its normal report is 883K.

    See the evidence
    This period
    1.3M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    883K
    Typical spread (median absolute deviation)
    48K
    How far from its usual level
    +5.0
    Same report last year
    865K
    History used
    2,359 days
    2023-06-15: 865K2023-06-30: 862K2023-07-14: 844K2023-07-31: 800K2023-08-15: 795K2023-08-31: 851K2023-09-15: 886K2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M2024-05-15: 1.3M2024-05-31: 1.4M2024-06-14: 1.3M
    the 14 Jun 2024 report24 earlier reportsnormal: 883K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 12 Jun 2024Short interest and volume change

    had 1.4M shares sold short in the 31 May 2024 report, 1.5× the same report last year.

    Same report last year: 914K; its normal report is 883K.

    See the evidence
    This period
    1.4M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    883K
    Typical spread (median absolute deviation)
    46K
    How far from its usual level
    +5.5
    Same report last year
    914K
    History used
    2,345 days
    2023-05-31: 914K2023-06-15: 865K2023-06-30: 862K2023-07-14: 844K2023-07-31: 800K2023-08-15: 795K2023-08-31: 851K2023-09-15: 886K2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M2024-05-15: 1.3M2024-05-31: 1.4M
    the 31 May 2024 report24 earlier reportsnormal: 883K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 25 May 2024Short interest and volume change

    had 1.3M shares sold short in the 15 May 2024 report, 1.5× the same report last year.

    Same report last year: 897K; its normal report is 883K.

    See the evidence
    This period
    1.3M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    883K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +5.1
    Same report last year
    897K
    History used
    2,329 days
    2023-05-15: 897K2023-05-31: 914K2023-06-15: 865K2023-06-30: 862K2023-07-14: 844K2023-07-31: 800K2023-08-15: 795K2023-08-31: 851K2023-09-15: 886K2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M2024-05-15: 1.3M
    the 15 May 2024 report24 earlier reportsnormal: 883K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 10 May 2024Short interest and volume change

    had 1.2M shares sold short in the 30 Apr 2024 report, 1.1× the same report last year.

    Same report last year: 1.1M; its normal report is 883K.

    See the evidence
    This period
    1.2M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    883K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +3.7
    Same report last year
    1.1M
    History used
    2,314 days
    2023-04-28: 1.1M2023-05-15: 897K2023-05-31: 914K2023-06-15: 865K2023-06-30: 862K2023-07-14: 844K2023-07-31: 800K2023-08-15: 795K2023-08-31: 851K2023-09-15: 886K2023-09-29: 797K2023-10-13: 835K2023-10-31: 970K2023-11-15: 927K2023-11-30: 936K2023-12-15: 931K2023-12-29: 879K2024-01-12: 845K2024-01-31: 961K2024-02-15: 926K2024-02-29: 911K2024-03-15: 849K2024-03-28: 939K2024-04-15: 768K2024-04-30: 1.2M
    the 30 Apr 2024 report24 earlier reportsnormal: 883K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 13 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 13 Mar 2024Filings record

    Director or officer change

  12. 30 Jun 2023Filings record

    Report will be filed late

  13. 5 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 5 May 2023Filings record

    Director or officer change

  15. 29 Dec 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 29 Dec 2022Filings record

    Director or officer change

  17. 9 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 9 Sep 2022Filings record

    Director or officer change

  19. 23 Mar 2022Filings record

    Director or officer change

  20. 18 Jan 2022Filings record

    Director or officer change

  21. 19 Nov 2021Filings record

    Director or officer change

  22. 15 Oct 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 15 Oct 2021Filings record

    Director or officer change

  24. 25 Mar 2021Short interest and volume change

    had 3.1M shares sold short in the 15 Mar 2021 report, 1.6× the same report last year.

    Same report last year: 2.0M; its normal report is 2.0M.

    See the evidence
    This period
    3.1M (the 15 Mar 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    106K
    How far from its usual level
    +5.9
    Same report last year
    2.0M
    History used
    1,172 days
    2020-03-13: 2.0M2020-03-31: 2.0M2020-04-15: 1.9M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.9M2020-07-31: 1.9M2020-08-14: 4.3M2020-08-31: 2.5M2020-09-15: 2.2M2020-09-30: 2.0M2020-10-15: 2.4M2020-10-30: 2.0M2020-11-13: 1.6M2020-11-30: 1.7M2020-12-15: 2.4M2020-12-31: 2.5M2021-01-15: 1.7M2021-01-29: 1.9M2021-02-12: 2.4M2021-02-26: 2.7M2021-03-15: 3.1M
    the 15 Mar 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 10 Mar 2021Short interest and volume change

    had 2.7M shares sold short in the 26 Feb 2021 report, 1.4× the same report last year.

    Same report last year: 2.0M; its normal report is 2.0M.

    See the evidence
    This period
    2.7M (the 26 Feb 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    90K
    How far from its usual level
    +3.8
    Same report last year
    2.0M
    History used
    1,155 days
    2020-02-28: 2.0M2020-03-13: 2.0M2020-03-31: 2.0M2020-04-15: 1.9M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.9M2020-07-31: 1.9M2020-08-14: 4.3M2020-08-31: 2.5M2020-09-15: 2.2M2020-09-30: 2.0M2020-10-15: 2.4M2020-10-30: 2.0M2020-11-13: 1.6M2020-11-30: 1.7M2020-12-15: 2.4M2020-12-31: 2.5M2021-01-15: 1.7M2021-01-29: 1.9M2021-02-12: 2.4M2021-02-26: 2.7M
    the 26 Feb 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 13 Jan 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 13 Jan 2021Filings record

    Director or officer change

  28. 13 Nov 2020Filings record

    Report will be filed late

  29. 26 Aug 2020Short interest and volume change

    had 4.3M shares sold short in the 14 Aug 2020 report, 4.1× the same report last year.

    Same report last year: 1.1M; its normal report is 1.9M.

    See the evidence
    This period
    4.3M (the 14 Aug 2020 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    59K
    How far from its usual level
    +12.3
    Same report last year
    1.1M
    History used
    959 days
    2019-08-15: 1.1M2019-08-30: 1.0M2019-09-13: 1.3M2019-09-30: 1.5M2019-10-15: 1.8M2019-10-31: 1.9M2019-11-15: 1.9M2019-11-29: 2.0M2019-12-13: 2.0M2019-12-31: 2.0M2020-01-15: 2.0M2020-01-31: 2.1M2020-02-14: 2.2M2020-02-28: 2.0M2020-03-13: 2.0M2020-03-31: 2.0M2020-04-15: 1.9M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.9M2020-07-31: 1.9M2020-08-14: 4.3M
    the 14 Aug 2020 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 14 Aug 2020Filings record

    Report will be filed late

  31. 29 Jun 2020Filings record

    Report will be filed late

  32. 13 May 2020Filings record

    Completed an acquisition or asset sale

  33. 9 Nov 2018Filings record

    Delisting notice or listing transfer

  34. 1 Nov 2018Filings record

    Delisting notice or listing transfer

  35. 7 Aug 2018Filings record

    Director or officer change (dated 6 Aug 2018)

  36. 15 May 2018Filings record

    Director or officer change

  37. 11 Apr 2018Filings record

    Changed its auditor

  38. 19 Mar 2018Filings record

    Changed its auditor

  39. 14 Feb 2018Filings record

    Report will be filed late

  40. 13 Nov 2017Filings record

    Report will be filed late

Showing the newest 40 of 58 entries; narrow the window or the kind of data to see older ones.

Not listed: 120 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001326205
Ticker
IGC
Domain
igcinc.us
Hq location
MD|POTOMAC|20854 (1 unverified)
Name
Hamsa Biopharma India Pvt. Ltd, HH Processors, LLC (formerly Holi Hemp, LLC), IGCare, LLC, IGC Enterprises Limited (IGC-ENT) and 9 more
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)147 records16 Feb 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1064 data points31 Mar 2010 to 3 Nov 2026
  • SEC Form 4 insider transactions15 records, 48 data points5 Dec 2017 to 27 Sep 2024
  • FINRA short interest (twice monthly)600 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4018 data points1 Aug 2018 to 20 Nov 2026